Login

Stem Cell Inc.

No Longer Reporting

The company has not filed an annual or quarterly report since its Q3 FY2023 10-Q, filed Nov 14, 2023. Its latest SEC filing is a REVOKED from Apr 14, 2026.

The sections below describe the company as of the FY2022 annual report.

What Did They Do?

Provides upfront financing to mining companies developing precious-metal properties in exchange for rights to a share of future metal revenues.

How Did They Make Money?

No revenue was reported.

Who Were Their Customers?

Works with mining companies that need funding to start or expand production through royalty agreements. The mine operator is the company's customer for the royalty interest and handles mining, marketing, and delivery of the metal.

How Were They Changing?

Since the FY2022 annual report
Latest quarter: Q3 FY2023, the three months to Sep 30, 2023
Revenue
vs $0 in Q3 FY2022
Net income
▼ −81% (Loss)
vs −$28K in Q3 FY2022
  • Jan 11, 2024 Auditor resigned, and company began searching for a replacement WWC resigned, and the company said it was searching for a new auditor.
  • Oct 30, 2023 Agreed to acquire spinal cord injury therapy technology The company said the agreement could move it into biotechnology, focused on stem cell regenerative medicine.

Who Did They Compete With?

Competes with Sprott Lending, Franco Nevada, Wheaton Precious Metals, and Royal Gold

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support